0 XP   0   0   0

Telo Genomics Corp
Buy, Hold or Sell?

I guess you are interested in Telo Genomics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Telo Genomics Corp

Let's start. I'm going to help you getting a better view of Telo Genomics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Telo Genomics Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Telo Genomics Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Telo Genomics Corp. The closing price on 2022-09-30 was $0.203 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Telo Genomics Corp Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Telo Genomics Corp.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Telo Genomics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Telo Genomics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--6.7%+6.7%
TTM--1.7%+1.7%
YOY-1.9%-1.9%
5Y--5.4%+5.4%
10Y--1.4%+1.4%
1.1.2. Return on Assets

Shows how efficient Telo Genomics Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • -12.3% Return on Assets means that Telo Genomics Corp generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Telo Genomics Corp:

  • The MRQ is -15.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.5%TTM-12.3%-3.2%
TTM-12.3%YOY-17.9%+5.6%
TTM-12.3%5Y-51.7%+39.4%
5Y-51.7%10Y-43.3%-8.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.5%-0.3%-15.2%
TTM-12.3%-0.2%-12.1%
YOY-17.9%0.3%-18.2%
5Y-51.7%-0.6%-51.1%
10Y-43.3%-0.8%-42.5%
1.1.3. Return on Equity

Shows how efficient Telo Genomics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • -15.9% Return on Equity means the company generated $-0.16 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Telo Genomics Corp:

  • The MRQ is -15.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -12.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-12.7%-3.2%
TTM-12.7%YOY-23.8%+11.0%
TTM-12.7%5Y-31.5%+18.8%
5Y-31.5%10Y-27.3%-4.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%1.0%-16.9%
TTM-12.7%0.5%-13.2%
YOY-23.8%1.1%-24.9%
5Y-31.5%-0.5%-31.0%
10Y-27.3%-0.5%-26.8%

1.2. Operating Efficiency of Telo Genomics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Telo Genomics Corp is operating .

  • Measures how much profit Telo Genomics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Telo Genomics Corp to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Telo Genomics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.2%+2.2%
TTM-0.5%-0.5%
YOY-2.9%-2.9%
5Y--1.3%+1.3%
10Y-0.7%-0.7%
1.2.2. Operating Ratio

Measures how efficient Telo Genomics Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.390-1.390
TTM-1.257-1.257
YOY-1.240-1.240
5Y-1.140-1.140
10Y-1.100-1.100

1.3. Liquidity of Telo Genomics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Telo Genomics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 6,904.5% means the company has $69.04 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Telo Genomics Corp:

  • The MRQ is 69.045. The company is very able to pay all its short-term debts. +2
  • The TTM is 55.502. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ69.045TTM55.502+13.543
TTM55.502YOY7.159+48.343
TTM55.5025Y13.312+42.190
5Y13.31210Y11.316+1.996
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ69.0452.320+66.725
TTM55.5022.526+52.976
YOY7.1592.728+4.431
5Y13.3122.587+10.725
10Y11.3162.811+8.505
1.3.2. Quick Ratio

Measures if Telo Genomics Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Diagnostics & Research industry mean)
  • A Quick Ratio of 121.3% means the company can pay off $1.21 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Telo Genomics Corp:

  • The MRQ is 1.213. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.940. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.213TTM0.940+0.273
TTM0.940YOY0.283+0.657
TTM0.9405Y0.339+0.601
5Y0.33910Y0.300+0.039
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2131.2130.000
TTM0.9401.378-0.438
YOY0.2831.510-1.227
5Y0.3391.358-1.019
10Y0.3001.389-1.089

1.4. Solvency of Telo Genomics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Telo Genomics Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Debt to Asset Ratio of 0.03 means that Telo Genomics Corp assets are financed with 2.6% credit (debt) and the remaining percentage (100% - 2.6%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.026. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.035. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.026TTM0.035-0.009
TTM0.035YOY0.209-0.174
TTM0.0355Y1.140-1.105
5Y1.14010Y0.994+0.147
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0260.408-0.382
TTM0.0350.404-0.369
YOY0.2090.444-0.235
5Y1.1400.459+0.681
10Y0.9940.452+0.542
1.4.2. Debt to Equity Ratio

Measures if Telo Genomics Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Debt to Equity ratio of 2.7% means that company has $0.03 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Telo Genomics Corp:

  • The MRQ is 0.027. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.036. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.027TTM0.036-0.009
TTM0.036YOY0.286-0.250
TTM0.0365Y0.234-0.198
5Y0.23410Y0.384-0.150
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0270.639-0.612
TTM0.0360.624-0.588
YOY0.2860.666-0.380
5Y0.2340.753-0.519
10Y0.3840.774-0.390

2. Market Valuation of Telo Genomics Corp

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Telo Genomics Corp.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -10.89 means the investor is paying $-10.89 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Telo Genomics Corp:

  • The EOD is -6.481. Company is losing money. -2
  • The MRQ is -10.887. Company is losing money. -2
  • The TTM is -12.776. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-6.481MRQ-10.887+4.406
MRQ-10.887TTM-12.776+1.889
TTM-12.776YOY-9.147-3.629
TTM-12.7765Y-4.775-8.002
5Y-4.77510Y-3.878-0.897
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-6.481-0.297-6.184
MRQ-10.887-0.489-10.398
TTM-12.776-1.203-11.573
YOY-9.1471.466-10.613
5Y-4.775-0.471-4.304
10Y-3.878-0.101-3.777
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Telo Genomics Corp.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Telo Genomics Corp:

  • The MRQ is -0.305. Very Bad. -2
  • The TTM is -0.029. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.305TTM-0.029-0.277
TTM-0.029YOY0.158-0.186
TTM-0.0295Y0.039-0.068
5Y0.03910Y0.0390.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.3050.013-0.318
TTM-0.0290.046-0.075
YOY0.1580.115+0.043
5Y0.0390.039+0.000
10Y0.0390.043-0.004

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Telo Genomics Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 6.27 means the investor is paying $6.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Telo Genomics Corp:

  • The EOD is 3.733. Neutral. Compare to industry.
  • The MRQ is 6.270. Seems overpriced? -1
  • The TTM is 5.408. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD3.733MRQ6.270-2.538
MRQ6.270TTM5.408+0.863
TTM5.408YOY9.140-3.732
TTM5.4085Y3.286+2.122
5Y3.28610Y2.629+0.657
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.7332.069+1.664
MRQ6.2702.239+4.031
TTM5.4083.132+2.276
YOY9.1404.289+4.851
5Y3.2863.318-0.032
10Y2.6293.015-0.386

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Telo Genomics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.0540.062-13%0.027+102%0.020+165%0.016+232%
Book Value Per Share Growth---0.0070.004-280%0.004-301%0.005-233%0.005-233%
Current Ratio--69.04555.502+24%7.159+864%13.312+419%11.316+510%
Debt To Asset Ratio--0.0260.035-24%0.209-87%1.140-98%0.994-97%
Debt To Equity Ratio--0.0270.036-25%0.286-91%0.234-88%0.384-93%
Dividend Per Share----0%-0%-0%-0%
Eps---0.009-0.008-10%-0.006-33%-0.024+181%-0.057+557%
Eps Growth--35.679-5.656+116%-23.756+167%-38.176+207%-38.176+207%
Gains Per Share---0.0070.004-280%0.004-301%0.005-233%0.005-233%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.880+14%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.733-68%6.2705.408+16%9.140-31%3.286+91%2.629+139%
Pe Ratio-6.481+40%-10.887-12.776+17%-9.147-16%-4.775-56%-3.878-64%
Peg Ratio---0.305-0.029-91%0.158-294%0.039-875%0.039-875%
Price Per Share0.203-68%0.3410.334+2%0.249+37%0.182+87%0.193+77%
Quick Ratio--1.2130.940+29%0.283+328%0.339+258%0.300+304%
Return On Assets---0.155-0.123-21%-0.179+15%-0.517+233%-0.433+179%
Return On Equity---0.159-0.127-20%-0.238+49%-0.315+98%-0.273+72%
 EOD+2 -1MRQTTM+6 -9YOY+11 -45Y+11 -410Y+12 -4

3.2. Fundamental Score

Let's check the fundamental score of Telo Genomics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.481
Price to Book Ratio (EOD)Between0-13.733
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.213
Current Ratio (MRQ)Greater than169.045
Debt to Asset Ratio (MRQ)Less than10.026
Debt to Equity Ratio (MRQ)Less than10.027
Return on Equity (MRQ)Greater than0.15-0.159
Return on Assets (MRQ)Greater than0.05-0.155
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Telo Genomics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5027.824
Ma 20Greater thanMa 500.215
Ma 50Greater thanMa 1000.231
Ma 100Greater thanMa 2000.241
OpenGreater thanClose0.203
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets3,319
Total Liabilities88
Total Stockholder Equity3,232
 As reported
Total Liabilities 88
Total Stockholder Equity+ 3,232
Total Assets = 3,319

Assets

Total Assets3,319
Total Current Assets3,284
Long-term Assets3,284
Total Current Assets
Cash And Cash Equivalents 3,163
Net Receivables 58
Total Current Assets  (as reported)3,284
Total Current Assets  (calculated)3,221
+/- 64
Long-term Assets
Property Plant Equipment 2
Long-term Assets  (as reported)35
Long-term Assets  (calculated)2
+/- 33

Liabilities & Shareholders' Equity

Total Current Liabilities48
Long-term Liabilities40
Total Stockholder Equity3,232
Total Current Liabilities
Accounts payable 48
Total Current Liabilities  (as reported)48
Total Current Liabilities  (calculated)48
+/-0
Long-term Liabilities
Long term Debt 40
Other Liabilities 0
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)40
Long-term Liabilities  (calculated)40
+/- 0
Total Stockholder Equity
Common Stock19,106
Retained Earnings -21,633
Total Stockholder Equity (as reported)3,232
Total Stockholder Equity (calculated)-2,527
+/- 5,759
Other
Capital Stock19,106
Common Stock Shares Outstanding 59,424
Net Invested Capital 3,272
Net Tangible Assets 3,199
Net Working Capital 3,237



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302015-06-30
> Total Assets 
471
696
3,524
4,920
3,991
2,401
1,644
2,286
1,751
430
424
312
322
263
440
1,713
1,244
1,169
1,001
1,829
2,164
3,839
3,930
3,740
3,319
3,3193,7403,9303,8392,1641,8291,0011,1691,2441,7134402633223124244301,7512,2861,6442,4013,9914,9203,524696471
   > Total Current Assets 
0
0
0
2,883
2,170
1,696
1,005
1,742
1,212
167
180
86
105
83
276
1,566
1,113
1,037
885
1,728
2,070
3,761
3,867
3,691
3,284
3,2843,6913,8673,7612,0701,7288851,0371,1131,56627683105861801671,2121,7421,0051,6962,1702,883000
       Cash And Cash Equivalents 
210
30
1,401
2,689
1,918
926
293
1,134
618
67
107
10
24
19
200
1,477
1,011
921
820
1,650
1,964
3,637
3,802
3,603
3,163
3,1633,6033,8023,6371,9641,6508209211,0111,477200192410107676181,1342939261,9182,6891,40130210
       Net Receivables 
0
0
0
102
136
256
288
245
135
41
43
47
51
37
49
62
75
49
48
61
76
97
45
54
58
58544597766148497562493751474341135245288256136102000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
217
180
164
147
131
131
116
100
94
78
62
49
35
3549627894100116131131147164180217000000000000
       Property Plant Equipment 
4
96
117
104
212
360
357
339
374
263
244
226
217
180
164
147
131
115
99
84
78
62
46
2
2
224662788499115131147164180217226244263374339357360212104117964
       Intangible Assets 
237
503
507
479
478
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000478479507503237
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
217
180
164
147
131
0
0
0
0
0
0
0
0
00000000131147164180217000000000000
> Total Liabilities 
233
854
510
237
480
683
695
943
822
744
999
1,050
1,165
1,308
1,623
496
260
393
282
228
201
154
206
78
88
88782061542012282823932604961,6231,3081,1651,050999744822943695683480237510854233
   > Total Current Liabilities 
167
854
510
237
480
670
682
931
822
744
999
1,050
1,165
1,308
1,623
496
260
353
242
188
161
114
166
38
48
48381661141611882423532604961,6231,3081,1651,050999744822931682670480237510854167
       Short-term Debt 
0
0
0
18
0
0
0
0
0
0
0
0
180
280
630
0
0
0
0
0
0
0
0
0
0
00000000006302801800000000018000
       Short Long Term Debt 
0
0
0
18
0
0
0
0
0
0
0
0
180
280
630
0
0
0
0
0
0
0
0
0
0
00000000006302801800000000018000
       Accounts payable 
70
587
461
213
480
667
679
928
781
633
423
474
985
1,028
993
449
237
301
222
173
161
102
138
38
48
48381381021611732223012374499931,02898547442363378192867966748021346158770
       Other Current Liabilities 
0
0
0
0
0
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000033300000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40
40
40
40
40
40
40
40
404040404040404000000000000000000
       Other Liabilities 
0
0
0
0
0
13
14
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000012141300000
       Deferred Long Term Liability 
0
0
0
0
0
10
10
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000009101000000
> Total Stockholder Equity
238
0
3,015
4,683
3,511
1,718
948
1,343
930
-314
-575
-738
-843
-1,045
-1,184
1,217
984
775
718
1,600
1,963
3,686
3,724
3,662
3,232
3,2323,6623,7243,6861,9631,6007187759841,217-1,184-1,045-843-738-575-3149301,3439481,7183,5114,6833,0150238
   Common Stock
381
1,133
6,234
7,384
7,738
8,024
8,316
8,996
11,575
11,441
11,741
11,741
11,741
11,741
11,741
14,303
14,278
14,326
14,407
15,562
16,186
18,234
18,719
19,106
19,106
19,10619,10618,71918,23416,18615,56214,40714,32614,27814,30311,74111,74111,74111,74111,74111,44111,5758,9968,3168,0247,7387,3846,2341,133381
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
4,085
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005,0004,0850000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-1,257
Operating Income-1,257-1,257
 
Operating Expense (+$)
Research Development604
Selling General Administrative653
Selling And Marketing Expenses-
Operating Expense1,2571,257
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income00
 
Pretax Income (+$)
Operating Income-1,257
Net Interest Income0
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,070-1,444
EBIT - interestExpense = -1,257
-1,070
-1,070
Interest Expense0
Earnings Before Interest and Taxes (ebit)-1,257-1,070
Earnings Before Interest and Taxes (ebitda)-1,008
 
After tax Income (+$)
Income Before Tax-1,070
Tax Provision--
Net Income From Continuing Ops-1,070-1,070
Net Income-1,070
Net Income Applicable To Common Shares-1,070
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net1870
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
3 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
9 minutes ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
9 minutes ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
12 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
14 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
16 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
16 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
18 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
18 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
19 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
25 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
27 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
27 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
29 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
29 minutes ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
29 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
31 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
31 minutes ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
33 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart